Market Overview:
The global hematology device market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of blood disorders, rising demand for point-of-care testing, and technological advancements in hematology devices. By type, the global hematology device market is segmented into analyzers, coagulation instruments, and other devices. The analyzers segment is expected to dominate the market during the forecast period owing to its growing demand for automated blood analysis systems. By application, the hospital/clinics segment is expected to account for a majority of the share in terms of revenue during 2018–2030 owing to an increase in number of hospitals and clinics across regions.
Product Definition:
A Hematology device is a medical device used to measure and monitor the levels of different types of blood cells in the body. This information can be used to diagnose and treat various blood-related disorders.
Analyzers:
An analyzers is a medical device used for analyzing chemical composition of blood, urine, bone marrow and other body fluids. It's major applications are in diagnosis of genetic disorders such as sickle cell anemia and thalassemia.
Coagulation Instrument:
Coagulation instruments are used for measuring the coagulation factors in the blood. The most commonly used instrument is hematology analyzer which measures different parameters such as prothrombin time (PT) and international normalized ratio (INR). INR measurement helps to evaluate the bleeding risk while taking medications for patients with chronic diseases such as cancer, diabetes, etc.
The global hematology devices market was valued at USD 4.6 billion in 2015.
Application Insights:
The hospital/clinics segment dominated the global hematology device market in 2017 and is expected to maintain its dominance over the forecast period. This can be attributed to a rising number of patients suffering from various blood disorders requiring hemato-oncology consultation. Increasing awareness about these disorders coupled with growing availability of advanced diagnostic devices is further driving the growth.
Furthermore, increasing R&D investments by major players for developing cost-effective and efficient diagnostic solutions is projected to boost industry growth during the study period. For instance, in January 2018 Siemens Healthineers launched new Cord Blood & Stem Cell Analysis System - HLA typing for cancer risk assessment based on cord blood stem cells data (CBBDS). The system provides clinicians with an easy tool for CBBDS analysis without having to send samples out or use expensive peripheral centers.
Regional Analysis:
North America dominated the global hematology device market in 2017. This can be attributed to favorable reimbursement policies, increasing prevalence of blood disorders, and rising adoption of advanced diagnostic technologies. In addition, presence of major players in this region is contributing towards growth. Increasing incidence of cancer & leukemia is also one among the factors responsible for its large share.
Growth Factors:
- Increasing incidence of blood disorders and cancer
- Growing demand for minimally invasive procedures
- Technological advancements in hematology devices
- Rising healthcare expenditure by governments and private players
- Emergence of new players in the market
Scope Of The Report
Report Attributes
Report Details
Report Title
Hematology Device Market Research Report
By Type
Analyzers, Coagulation Instrument, Other
By Application
Hospital/Clinics, Independent Diagnostic, Laboratories
By Companies
HORIBA, Abbott Laboratories, Siemens, Bio-Rad Laboratories, Danaher, BD, Alere, Roche, Sekisui, Axis-Shield, HORIBA
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
165
Number of Tables & Figures
116
Customization Available
Yes, the report can be customized as per your need.
Global Hematology Device Market Report Segments:
The global Hematology Device market is segmented on the basis of:
Types
Analyzers, Coagulation Instrument, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital/Clinics, Independent Diagnostic, Laboratories
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- HORIBA
- Abbott Laboratories
- Siemens
- Bio-Rad Laboratories
- Danaher
- BD
- Alere
- Roche
- Sekisui
- Axis-Shield
- HORIBA
Highlights of The Hematology Device Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Analyzers
- Coagulation Instrument
- Other
- By Application:
- Hospital/Clinics
- Independent Diagnostic
- Laboratories
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hematology Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A hematology device is a medical device that helps diagnose and treat blood disorders. Hematology devices can include blood pressure cuffs, monitors, and other equipment used to measure the amount of oxygen in a person's blood or the level of carbon dioxide in their breath.
Some of the major companies in the hematology device market are HORIBA, Abbott Laboratories, Siemens, Bio-Rad Laboratories, Danaher, BD, Alere, Roche, Sekisui, Axis-Shield, HORIBA.
The hematology device market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Hematology Device Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Hematology Device Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Hematology Device Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Hematology Device Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Hematology Device Market Size & Forecast, 2018-2028
4.5.1 Hematology Device Market Size and Y-o-Y Growth
4.5.2 Hematology Device Market Absolute $ Opportunity
Chapter 5 Global Hematology Device Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Hematology Device Market Size Forecast by Type
5.2.1 Analyzers
5.2.2 Coagulation Instrument
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Hematology Device Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Hematology Device Market Size Forecast by Applications
6.2.1 Hospital/Clinics
6.2.2 Independent Diagnostic
6.2.3 Laboratories
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Hematology Device Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Hematology Device Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Hematology Device Analysis and Forecast
9.1 Introduction
9.2 North America Hematology Device Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Hematology Device Market Size Forecast by Type
9.6.1 Analyzers
9.6.2 Coagulation Instrument
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Hematology Device Market Size Forecast by Applications
9.10.1 Hospital/Clinics
9.10.2 Independent Diagnostic
9.10.3 Laboratories
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Hematology Device Analysis and Forecast
10.1 Introduction
10.2 Europe Hematology Device Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Hematology Device Market Size Forecast by Type
10.6.1 Analyzers
10.6.2 Coagulation Instrument
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Hematology Device Market Size Forecast by Applications
10.10.1 Hospital/Clinics
10.10.2 Independent Diagnostic
10.10.3 Laboratories
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Hematology Device Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Hematology Device Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Hematology Device Market Size Forecast by Type
11.6.1 Analyzers
11.6.2 Coagulation Instrument
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Hematology Device Market Size Forecast by Applications
11.10.1 Hospital/Clinics
11.10.2 Independent Diagnostic
11.10.3 Laboratories
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Hematology Device Analysis and Forecast
12.1 Introduction
12.2 Latin America Hematology Device Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Hematology Device Market Size Forecast by Type
12.6.1 Analyzers
12.6.2 Coagulation Instrument
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Hematology Device Market Size Forecast by Applications
12.10.1 Hospital/Clinics
12.10.2 Independent Diagnostic
12.10.3 Laboratories
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Hematology Device Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Hematology Device Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Hematology Device Market Size Forecast by Type
13.6.1 Analyzers
13.6.2 Coagulation Instrument
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Hematology Device Market Size Forecast by Applications
13.10.1 Hospital/Clinics
13.10.2 Independent Diagnostic
13.10.3 Laboratories
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Hematology Device Market: Competitive Dashboard
14.2 Global Hematology Device Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 HORIBA
14.3.2 Abbott Laboratories
14.3.3 Siemens
14.3.4 Bio-Rad Laboratories
14.3.5 Danaher
14.3.6 BD
14.3.7 Alere
14.3.8 Roche
14.3.9 Sekisui
14.3.10 Axis-Shield
14.3.11 HORIBA
